The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

Report Highlights

The U.S. biodefense-related rapid pathogen identification and treatment market should reach $518.3 million by 2026 from $366.3 million in 2021 at a compound annual growth rate (CAGR) of 7.2% for the forecast period of 2021 to 2026.

Report Includes

• 79 tables
• An overview of the U.S. market for biodefense-related rapid pathogen identification and treatments
• Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
• Discussion of key market dynamics (DROs), technological advancements, and regulatory landscape in the context of biodefense-related rapid pathogens
• Evaluation and forecast the biodefense-related pathogen detection products market size in dollar value terms, and corresponding market share analysis by type, testing method, device type, technology, application etc.
• Highlights of emerging technology trends, opportunities and gaps estimating current and future demand for infectious agents with detection, vaccine and treatment information, ongoing R&D activities, and clinical trials etc.
• Review of the infectious agents including smallpox, anthrax, plague and tularaemia, as well as coverage of potentially harmful chemical toxins that are used in biological warfare situations including sarin gas, ricin and botulinum
• Impact of COVID-19 on bioinformatics research and new developments relate to biodefense-related diagnostic tools
• Review of patents issued for rapid pathogen identification and industry specific new developments
• Insight into the recent industry strategies and competitive landscape of the major players operating within the global market, along with their company share analysis
• Profile descriptions of the leading industry players, including ANP Technologies, Biomerieux, Haztech, Menon Biosensors, Merck, Thermo Fisher Scientific and GlaxoSmithKline

Report Scope

This report examines the current and future market potential of the U.S. biodefense-related rapid pathogen identification and treatment market. It offers a detailed analysis of the competitive environment, regulatory scenario, technological advancement, drivers and restraints, and it identifies opportunities and trends in market growth. The report also covers market projections to 2026.

For market estimates, data is provided for the following year 2019, 2020, 2021 and 2026. Year 2020 is the base year, and forecast through year 2026.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
• Metal-organic Frameworks: Global Markets (AVM200B)
• Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
• Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
• Surgical Equipment: Technologies and Global Markets (HLC154C)